GO8110: Blood Borne Viruses (BBV) and Sexually Transmissible Infections (STI) Research Program

This grant program is delivered, in part, through the collection of data, ongoing surveillance, and pertinent research and evaluation activities related to the BBV and STI outlined in the National BBV and STI Strategies, namely: National Hepatitis B Strategy National Hepatitis C Strategy National STI Strategy National Aboriginal and Torres Strait Islander BBV and STI Strategy National HIV Strategy.

The Department’s First National BBV and STI Research Strategy 2021-2025 and its future iterations (the National BBV and STI Research Strategy), sets out the aims and objectives for the multi-disciplinary research activities undertaken within Australia and supports the implementation of the related National BBV and STI Strategies.

By enabling and focussing on the conduct of BBV and STI research, the Research Strategy aims to identify challenges, barriers and opportunities to achieve the agreed national goals and targets of the National BBV and STI Strategies.

The Research Strategy also contains a series of Guiding Principles that have the potential to advance the BBV and STI policy landscape and increase the community engagement with research.

The purpose of this grant opportunity is to build on the success of the 2021-2025 BBV and STI Research Program, by continuing to fund eligible organisations to undertake critical BBV and STI research activities that: Continue to build on the evidence base that informs the development, implementation, monitoring and evaluation of BBV and STI health policy and improves practices in Australia.

Focus on reducing morbidity, mortality, stigma and discrimination, increasing access to new biomedical interventions, and improving quality of life and health outcomes for people living with, or at risk of, BBV and STI.

To view the grant opportunity documents, please select the red "Grant Opportunity Documents" button on the left-hand side.

To be eligible an applicant must be one of the following entity types: Indigenous Corporation (registered under the Corporations (Aboriginal and/or Torres Strait Islander) Act 2006), Company, Cooperative, Incorporated Association, Sole Trader, Statutory Entity, or Partnership.

If applying as Trustee on behalf of a Trust, the Trustee must have an eligible entity type.

Consortium applications are acceptable provided a lead organisation (which meets eligibility) is solely accountable to the Commonwealth and only the lead organisation submits the application and enters into any grant agreement.

Applicants must not receive funding from another government source for the same purpose.

Successful applicants and relevant personnel must maintain registrations/checks relevant to delivery (e.g.

Working with Children/Working with Vulnerable People checks where relevant) and declare compliance with relevant legislation/policies and research ethics/codes (including Workplace Gender Equality Act reporting requirements where applicable, Commonwealth Child Safe Framework, NHMRC/ARC/UA Australian Code for the Responsible Conduct of Research and related National Statement on Ethical Conduct in Human Research, and the Australian Code for the care and use of animals for scientific purposes).